Skip to main content
. 2021 Jun 16;9:680108. doi: 10.3389/fpubh.2021.680108

Figure 3.

Figure 3

Modifiable factors. (A) Forest plots (fixed effects model) of meta-analysis on the association between cytomegalovirus co-infection and the risk of mortality in non-HIV-related Pneumocystis pneumonia. (B) Forest plots (fixed effects model) of meta-analysis on the association between pneumothorax and the risk of mortality in non-HIV-related Pneumocystis pneumonia. (C) Forest plots (fixed effects model) of meta-analysis on the association between prophylaxis and the risk of mortality in non-HIV-related Pneumocystis pneumonia. (D) Forest plots (fixed effects model) of meta-analysis on the association between the use of corticosteroids after admission and the risk of mortality in non-HIV-related Pneumocystis pneumonia. (E) Forest plots (random effects model) of meta-analysis on the association between invasive ventilation during hospitalization and the risk of mortality in non-HIV-related Pneumocystis pneumonia. (F) Forest plots (random effects model) of meta-analysis on the association between lactate dehydrogenase and the risk of mortality in non-HIV-related Pneumocystis pneumonia. (G) Forest plots (random effects model) of meta-analysis on the association between albumin and the risk of mortality in non-HIV-related Pneumocystis pneumonia. (H) Forest plots (random effects model) of meta-analysis on the association between lymphocytes and the risk of mortality in non-HIV-related Pneumocystis pneumonia. (I) Forest plots (random effects model) of meta-analysis on the association between time from onset of symptoms to treatment and the risk of mortality in non-HIV-related Pneumocystis pneumonia.